ESİN TUNA Cep: 0531 372 44 53 E-mail: esin.tuna@polarsaglik.com / esntna@hotmail.com İŞ DENEYİMİ 16.12.2013 : Polar Sağlık Ekonomisi ve Politikası Danışmanlık (Ankara) Sağlık Ekonomisi ve Politikası Uzmanı 08.10.2012 06.12.2013: Bayer (Ankara) Sağlık Politikası Uzmanı (Pazar Erişim Departmanı) EĞİTİM DURUMU 2014-..: Hacettepe Üniversitesi Sosyal Bilimler Fakültesi, Sağlık Ekonomisi ve Farmakoekonomi Programı, Yüksek Lisans Öğrencisi 2011- : Hacettepe Üniversitesi Eczacılık Fakültesi, Biyofarmasötik ve Farmakokinetik Bilim Dalı/ Farmasötik Teknoloji Anabilim Dalı, Yüksek Lisans Öğrencisi 2011-2006: Hacettepe Üniversitesi, Eczacılık Fakültesi Erasmus La Faculté des Sciences Pharmaceutiques et Biologiques de Lille 08.09.2008-26.06.2009 2006-2003: Ankara Atatürk Anadolu Lisesi 2003-1998: TED Ankara Koleji STAJLAR 24.04.2012-11.05.2012 İlko Argem (Ankara) Ar-Ge Departmanı (Gönüllü staj) 06.2011-09.2011 İlaç Eczacılık Genel Müdürlüğü (Ankara) Farmakoekonomi Departmanı (Gönüllü staj) 1
02.2011-05.2011 Sibel Ersoy Eczanesi (Ankara) (Staj) 06.2010-07.2010 Fresenius Medical Care (İstanbul) Ruhsatlandırma Departmanı (Staj) 08.2009-09.2009 Sibel Ersoy Eczanesi (Ankara) (Staj) 11.2008-06.2009 Pharmacie du Faubourg (Fransa) Stajyer Eczacı (Gönüllü staj) SERTİFİKALAR Elements of Pharmaceutical / Biotech Pricing Short Course ISPOR 17th Annual European Congress 11.2014 (Amsterdam, Hollanda) Risk-sharing/Performance-based Arrangements for Drugs and Other Medical Products Short Course ISPOR 17th Annual European Congress 11.2014 (Amsterdam, Hollanda) Discrete Event Simulation for Economic Analyses Short Course ISPOR 17th Annual European Congress 11.2014 (Amsterdam, Hollanda) Reimbursement Systems for Pharmaceuticals in Europe Short Course ISPOR 17th Annual European Congress 11.2014 (Amsterdam, Hollanda) Olağanüstü Verimlilik için 5 Seçim Eğitimi Franklin Covey 11.2013 (İstanbul) Advocacy Eğitimi Bayer 04.2013 (İstanbul) Sağlık Ekonomisi Eğitimi Bayer 04.2013 (İstanbul) Sunum Teknikleri Eğitimi İzgören Akademi 27.10.2011 (Ankara) 18. Uluslararası Mikroenkapsülasyon Sempozyumu 14.09.2011 (Antalya) International Symposium on Drug Research & Development 'From Chemistry to Medicine' DRD 2011 MAGUM 29.05.2011 (Antalya) 34. EPSA Yıllık Kongresi 15.04.2011 (Lizbon/PORTEKİZ) Life Long Learning Certificate 15.04.2011 2
23rd Annual Euromeeting of DIA 30.03.2011 (Cenevre/İSVİÇRE) 7. EPSA Sonbahar Kongresi- Katılım Sertifikası (Helsinki/FİNLANDİYA) EPSA (European Pharmaceutical Students Association) - 30.10.2010 Her Yönüyle Eczacılık Sempozyumu Anadolu Üniversitesi 23.05.2010 (Eskişehir) 33. EPSA Yıllık Kongresi- Katılım Sertifikası (Krakow/POLONYA) EPSA - 02.05.2010 SINAV BİLGİLERİ TOEFL-IBT (Test of English as a Foreign Language - Internet based test) (95) o ETS - 2012 KPDS (Kamu Personeli Dil Sınavı) (87.5) OSYM - 2011 ALES (Akademik Personel ve Lisansüstü Eğitimi Giriş Sınavı) (96.2) OSYM - 2010 YABANCI DİL İngilizce: İleri seviyede Fransızca: Başlangıç seviyesi BİLGİSAYAR MS Office programları; Windows, Word, Powerpoint, Excel PROJELER 15.10.2012-22.10.2012 Antibiyotikler Şeker Değildir adlı Avrupa Birliği Projesi nin yazımı ve koordinatörlüğü 01.10.2011-08.10.2011 Kanserde Erken Teşhis Hayat Kurtarır adlı Avrupa Birliği Projesi nin yazımı ve koordinatörlüğü 3
MAKALE ve POSTERLER Makale: 1. Results of Reference Pricing and Reimbursement Discount Rate Schemes of Turkey ISPOR Value in Health Vol 14 No 2 Posterler: 1. Comparing Cost of Therapeutic Plasma Exchange and Intravenous Immunoglobulin Infusion in Treating Guillain-Barre Syndrome ISPOR 15th Annual European Congress (3-7 Kasım 2012) - Berlin/ ALMANYA 2. Possible Budget Impact of Internal Reference Pricing for Statins in Turkey ISPOR 15th Annual European Congress (3-7 Kasım 2012) - Berlin/ ALMANYA 3. Net Tax Revenue with a National Based Rotavirus Vaccination Program in Turkey ISPOR 15th Annual European Congress (3-7 Kasım 2012) -Berlin/ ALMANYA 4. The Cost-of-Disease of Thromboembolic and Hemorrhagic Complications Associated with Atrial Fibrillation and its Treatment in Turkey: An Expert Panel Approach for Estimation of Costs 5. The Cost-of-Disease of Deep Venous Thrombosis and Its Short and Long-Term Clinical Consequences in Turkey: An Expert Panel Approach for Estimation of Costs 6. The Cost Effectiveness of Rivaroxaban for the Prevention of Stroke in Patients with Atrial Fibrillation (AF) in Turkey 7. The Cost Effectiveness of Rivaroxaban Compared to Enoxaparin Plus Adjusted-Dose Warfarin for the Treatment of Deep Venous Thrombosis (DVT) in Turkey 8. Whether The Treatment Expenditures or The Pharmaceutical Expenditures of Social Security Institution (SSI) Have a Higher Increase Rate Between 2005 and 2011 in Turkey? 9. Comparison Retail Prices of Drug Prices Between Turkey and European Countries 10. Supplementary Health Insurance in Turkey 11. How Co-Payment Mechanism Has Changed Patients' Perception Towards OTC Type Products? 12. Classification of Drugs Bringing From Abroad in Turkey According to Their ATC Codes ISPOR 6th Asia Pacific Conference (6-9 Eylül 2014) - Beijing/ ÇİN 4
13. Development of HTA In Turkey 14. Availability of Risk Sharing Agreements in the Turkish Pharmaceutical Sector 15. Cost-Analysis of Chronic Idiopathic Urticaria Disease 16. Value of Life And Cost of Pre-Mature Deaths With the Perspective of Productivity As Net Tax Revenue for Turkey 17. Value of Life And Cost of Pre-Mature Deaths With the Perspective of Productivity As Net Tax Revenue: A Comparison in USA, Canada, Japan and Australia 18. Value of Life And Cost of Pre-Mature Deaths With the Perspective of Productivity As Net Tax Revenue: A Comparison in France, Germany, Italy, Spain, United Kingdom 19. Value of Life And Cost of Pre-Mature Deaths With the Perspective of Productivity As Net Tax Revenue: A Comparison in Argentina, Brazil and Mexico 5